Download original image
Fig. 1. Method comparison between each measurement via Passing-Bablok analysis. (A, B) Cobas c702 and Atellica CH930 cells: intercept, 0.8545 (95% confidence interval [CI], 0.2412 to 1.556); slope, 0.9866 (95% CI, 0.9522 to 1.019). (C, D) Fairbanks method 2 and Cobas c702: intercept, –2.908 (95% CI, –4.008 to –1.868); slope, 1.007 (95% CI, 0.9595 to 1.052). (E, F) Fairbanks method 2 and Atellica CH930: intercept, –1.806 (95% CI, –2.981 to –0.5902); slope, 0.9800 (95% CI, 0.9282 to 1.042). The instrument was from the following company: Cobas c702 (Roche Diagnostics, Indianapolis, IN, USA) and Atellica CH930 (Siemens, Erlangen, Germany). Abbreviation: pHb, plasma hemoglobin.
Lab Med Qual Assur 2021;43:208~213 https://doi.org/10.15263/jlmqa.2021.43.4.208
© Lab Med Qual Assur